Answers Logo
Search

You can view polls created in the following languages.
English
German
French
Spanish
Dutch
Romanian
Norwegian
Portugese
Serbo Croatian
Arabic
PollDaddy Answers > All Polls By This User >

A recently published study in the New England Journal of Medicine concluded that post-marketing safety concerns were more likely for medicines approved by the



This is precisely the problem with user-fee mandated deadlines.

Interesting statistics, but not enough to make a sound determination.

Hogwash. The study’s methodology was wrong.

Seems plausible given the pressure the agency is under for speedy review times.

Vote



See this poll in action: This poll is currently posted at this URL...
http://www.envisagemag.com/

0 Comments

There are no comments for this poll. You can enter one below.


Comments have been disabled for this poll.

User

This user does not have a PollDaddy profile set up yet...



Results

Click on the link below to see the results of this poll.

View Poll Results